Michael Cronquist Christensen, DrPH

  • 2Articles
  • 22.2KReads
  • 2017–2023Active
  • 6Collaborators
  • 115Citations

About

Michael Cronquist Christensen, DrPH is affiliated with H. Lundbeck A/S, Valby, Denmark. Michael Cronquist Christensen has authored or co-authored 2 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2017 and 2023. Their work focuses on Depression (MDD).

Publications

JCP
Vortioxetine vs Desvenlafaxine in Patients With MDD
Original Research

Vortioxetine vs Desvenlafaxine in Patients With MDD

May 22, 2023

Compared with desvenlafaxine, vortioxetine was associated with higher rates of symptomatic and functional remission, better daily and social functioning, and greater treatment satisfaction in patients with major depression and...
, , , et al
JCP
Original Research

Vortioxetine and Cognition in Working Patients With MDD

January 25, 2017

Many studies have shown that people with MDD have reduced work productivity, and cognitive symptoms are common. This study looked at whether antidepressant treatment with vortioxetine would improve cognitive...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe